AL
Alector, Inc.
ALEC · NASDAQ
$2.04 -7.08% (-$0.15)
1M -0.49%
Market Cap $225.9M
P/E Ratio -
Div. Yield -
ROE 531.04%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 16.30x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 46.00%
Book val. growth 47.72%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 360.92%
Net margin 850.13%
Op. margin 914.56%
Quality
1 /100
Poor ROIC 67.73%
ROE 531.04%
ROA 58.10%
Debt
100 /100
Low Current ratio 5.26x
Debt/Equity N/A
Int. coverage N/A
Stability
53 /100
Moderate Beta 0.58x
Rev. volatility 41.77%
EPS volatility 17.08%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ALEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Arnon Rosenthal
Employees
103
Headquarters
South San Francisco
Nadcházející události
05 LIS
Earnings
Upcoming earnings report